1,960 hedge funds and large institutions have $144B invested in Pfizer in 2016 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 885 increasing their positions, 763 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less call options, than puts

Call options by funds: $ | Put options by funds: $

less first-time investments, than exits

New positions opened: | Existing positions closed:

1% less funds holding

Funds holding: 1,9891,960 (-29)

5% less capital invested

Capital invested by funds: $152B → $144B (-$8.2B)

18% less funds holding in top 10

Funds holding in top 10: 286234 (-52)

Holders
1,960
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
234
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.25B
Puts
$2.33B
Net Calls
Net Calls Change

Top Buyers

1 +$351M
2 +$340M
3 +$281M
4
Renaissance Technologies
Renaissance Technologies
New York
+$240M
5
JP Morgan Chase
JP Morgan Chase
New York
+$183M
Name Holding Trade Value Shares
Change
Change in
Stake
1901
$114K
1902
$113K
1903
$100K
1904
$100K
1905
$95K
1906
$95K
1907
$92K
1908
$92K
1909
$90K
1910
$88K
1911
$86K
1912
$81K
1913
$77K
1914
$76.4K
1915
$76K
1916
$76K
1917
$75K
1918
$74K
1919
$73K
1920
$73K
1921
$72K
1922
$70.6K
1923
$68K
1924
$67K
1925
$57K